SANDOSTATINE LAR subst sèche 10 mg c solv ser pré
7680531610041
CH-53161
H01CB02
07.16.2.
Reimbursement limitations:
SANDOSTATIN
Tumeurs du système endocrine gastroentéropancréatique.
Acromégalie qui ne réagit pas ou pas suffisamment à d'autres …
1 / 3
google
Details
- Product number
- 5316104
- CPT
- -
- Packaging group
- 1 x 10 mg
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio sicca: octreotidum 10 mg ut octreotidi acetas 11.2 mg, poly(lactidum-co-glycolidum), mannitolum, pro vitro. Solvens: carmellosum natricum corresp. natrium 1.512 mg, mannitolum, poloxamerum 188, aqua ad iniectabile q.s. ad solutionem pro 2.0 ml.
Articles (1)
Sandostatin LAR 10 mg Fertigspritzen, Injektionspräparat
Injektionspräparat
1 x 10 mg
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRS
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
SOLV
|
- | Substance | HNIDK |
|
PRS
|
11.2 MG | Substance | WIZUS |
|
SOLV
|
1.512 MG | Substance | HBESI |
|
SOLV
|
- | Substance | HNIDK |
|
PRS
|
- | Substance | HNIDK |
|
PRS
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 560.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1997
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 53161
- Drug name
- Sandostatin LAR, Fertigspritze/Injektionspräparat
- Galenic form
- PULMR
- ATC Code
- H01CB02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 29/08/1995
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SANDOSTATINE LAR subst sèche 10 mg c solv ser pré
- Description (DE)
- SANDOSTATIN LAR Trockensub 10 mg c Solv Fertspr
- Market launch
- 02/10/2003
- Narcotic (BTM)
- No